Archive - November 2014
EMA Announces Final Steps for its Clinical Trial Data Policy
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
Karyopharm Therapeutics Inc. and Clinipace Worldwide Announce Preferred Provider Agreement
On the Ground in China Trials
Scaling LC gradients and analytical March madness
EFGCP Focuses on Implementing Risk-Based Monitoring
DIA Makes Key Appointment in China
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth